Technical / White Paper

Experience foam for topical drug delivery

Published

Format: PDF file | Document type: Technical / White Paper

Experience foam for topical drug delivery

Pharmaceutical foams are becoming more popular probably due to more topical medicines being switched to OTC and the need to innovate and differentiate ‘brands’ and an increasing awareness of the importance of formulating to deliver sensorial benefits and positive impact on patient experience and adherence. Gattefossé, as a leading provider of excipients for the pharmaceutical industry, manufactures solubilizers and texturizers for skin drug delivery. In this white paper we give formulation tips for propellant and propellant-free foams with guidelines on how to formulate and select excipients and case studies with model drugs.

Latest content from Gattefossé

SEDDS for oral peptide delivery: Gattefossé insight

Content provided by Gattefossé

SEDDS for oral peptide delivery: Gattefossé insight

Peptide therapeutics are on the rise due to their high potency, specific mode of action and safety. Currently, more than 60 peptides are available on the market. About 140 are in clinical trials and 500 are in preclinical development (Fosgerau and Hoffmann,...

Related resources from Gattefossé

Show more

Supplier info centre